Introducing the need for lung transplantation in children with cystic fibrosis: parental experiences

Lisa Lang1, Alistair J A Duff, Keith G Brownlee

  • 1School of Medicine, Leeds University, Leeds, UK.

Insights

Parents of children with cystic fibrosis (CF) shared their views on lung transplantation (LTx) timing. Their recommendations can inform clinical practice for pediatric CF patients considering LTx.

Area of Science:

  • Medical research
  • Pediatric pulmonology
  • Transplant surgery

Background:

  • Cystic Fibrosis (CF) is a genetic disorder leading to end-stage lung disease.
  • Lung transplantation (LTx) is the primary treatment for advanced CF.
  • Decisions regarding LTx timing significantly impact children and families.

Purpose of the Study:

  • To explore parental perspectives on the timing of lung transplantation (LTx) for children with cystic fibrosis (CF).
  • To gather recommendations from parents referred to a national transplant center for pediatric LTx evaluation.
  • To inform clinical practice and develop an emergent protocol for LTx consideration in pediatric CF.

Main Methods:

  • Semi-structured telephone interviews were conducted with parents of children with CF.
  • Content Analysis was used to analyze parental responses.
  • The study focused on parents who had considered LTx for their child.

Main Results:

  • Parental insights into the medical and psychological implications of LTx timing were gathered.
  • Specific recommendations from parents regarding LTx introduction were identified.
  • An emergent protocol based on parental feedback was developed.

Conclusions:

  • Parental experiences and recommendations are crucial for optimizing the LTx process in pediatric CF.
  • Integrating parental perspectives can improve the medical and psychological support for families.
  • Findings have direct implications for clinical practice in pediatric lung transplantation for CF.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...